Because literature monitoring deserves better than workarounds and retrofitted tools.
Biologit is the only technology company focused entirely on literature monitoring for pharmacovigilance. Founded by a PV expert and an engineering leader, we built our platform to solve a long-standing challenge: how to track global and local literature efficiently, reliably, and at scale.
Our platform brings AI, automation, and regulatory transparency to the full range of sources, from global databases to local print publications. Trusted by leading pharma and CROs, we help PV teams cut risk, reduce manual effort, and stay ahead of rising demand
This is our de facto literature assessment tool as far as our PV practice is concerned
Name Surname – Company Logo Here (In White)
Nicole is CEO and co-founder of Biologit, where she’s spent the last five years building the only AI-powered platform focused solely on literature monitoring for pharmacovigilance.
A trained immunologist and seasoned PV professional, she brings scientific rigour and deep regulatory insight to the role. Nicole has led Biologit from concept to global adoption, with clients in 170+ countries and a platform aligned to GxP and the EU AI Act. With 25+ years’ experience across pharma, CROs, regulators and research, she’s held leadership roles including EEA QPPV and RPPV.
Bruno is CTO and co-founder of Biologit, where he leads the design and development of its AI-powered platform for literature monitoring in pharmacovigilance. An experienced technologist with a 20-year career spanning cloud infrastructure, fintech, healthtech, and AI, he brings deep engineering insight to every layer of the platform. Before co-founding Biologit, Bruno held senior roles at Amazon and Oracle, delivering complex, large-scale systems at global scale. At Biologit, he has fused platform engineering with regulatory-grade precision to help reshape how safety teams monitor scientific literature.
As Biologit’s COO, Jean leads strategy and operations, driving the company’s scale-up and global delivery. She brings deep commercial and scientific insight from over a decade in consulting, general management and global life sciences strategy. Prior to joining Biologit, Jean held senior roles at IQVIA, working across multiple therapeutic areas and service lines. Her experience spans clinical research, organisational design, and operational excellence in complex, regulated environments. Jean holds a PhD in Neuroscience from the University of Cambridge and combines scientific depth with sharp operational leadership.
We’re solving real-world challenges in pharmacovigilance with smart, human-led technology.
Want to stay ahead of what’s changing in pharmacovigilance, AI, and literature monitoring? Our resource hub is where we share real-world insights, expert commentary, and practical tools to help PV teams work smarter and stay compliant.
From whitepapers and webinars to use cases and feature updates, we keep it focused.
Biologit delivers efficiency, compliance, and control — all in one place
